352 / 1138
/
Matthias Guckenberger - DEGRO 2015
31
Late recurrences in stage I NSCLC
Large majority of recurrences within 3 (max. 5) years
29.08.2015
Swedish phase II trial:
N=57
Median FU 41.5 months
3 x 15Gy @ 67%
Japanese prospective study:
N=180
Median FU 52.5 months
4 x 12Gy @ isocenter